BI Asset Management Fondsmaeglerselskab A S Invests $5.24 Million in AptarGroup, Inc. $ATR

Key Points

• BI Asset Management Fondsmaeglerselskab A S acquired a new position in AptarGroup, purchasing 35,328 shares valued at approximately $5.24 million during the first quarter.
• A number of institutional investors have increased their holdings in AptarGroup, with Victory Capital Management boosting its position by 12.6%, owning over 2.2 million shares worth $329.28 million.
• AptarGroup recently announced a quarterly dividend of $0.45, representing an annualized dividend of $1.80, yielding 1.3% with a payout ratio of 30.98%.

BI Asset Management Fondsmaeglerselskab A S purchased a new stake in shares of AptarGroup, Inc. (NYSE:ATR - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 35,328 shares of the industrial products company's stock, valued at approximately $5,242,000. BI Asset Management Fondsmaeglerselskab A S owned approximately 0.05% of AptarGroup at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ATR. Barclays PLC lifted its holdings in AptarGroup by 83.5% during the fourth quarter. Barclays PLC now owns 54,138 shares of the industrial products company's stock valued at $8,506,000 after purchasing an additional 24,639 shares in the last quarter. Commerce Bank lifted its holdings in AptarGroup by 9.6% during the fourth quarter. Commerce Bank now owns 2,574 shares of the industrial products company's stock valued at $404,000 after purchasing an additional 225 shares in the last quarter. Forum Financial Management LP purchased a new position in AptarGroup during the fourth quarter valued at approximately $221,000. MetLife Investment Management LLC lifted its holdings in AptarGroup by 9.3% during the fourth quarter. MetLife Investment Management LLC now owns 37,502 shares of the industrial products company's stock valued at $5,892,000 after purchasing an additional 3,196 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of AptarGroup by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 3,664 shares of the industrial products company's stock worth $576,000 after buying an additional 2,314 shares in the last quarter. Hedge funds and other institutional investors own 88.52% of the company's stock.

Insider Buying and Selling at AptarGroup

In other news, insider Gael Touya sold 3,300 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $152.62, for a total value of $503,646.00. Following the sale, the insider owned 33,963 shares of the company's stock, valued at approximately $5,183,433.06. This represents a 8.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Kimberly Chainey sold 1,671 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $152.79, for a total transaction of $255,312.09. Following the completion of the sale, the executive vice president directly owned 11,088 shares in the company, valued at approximately $1,694,135.52. This represents a 13.10% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.68% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on ATR shares. Wall Street Zen raised shares of AptarGroup from a "hold" rating to a "buy" rating in a report on Wednesday, May 14th. Raymond James Financial reissued an "outperform" rating and issued a $172.00 target price (down previously from $182.00) on shares of AptarGroup in a report on Monday, August 4th. Finally, Wells Fargo & Company reissued an "overweight" rating and issued a $153.00 target price (down previously from $173.00) on shares of AptarGroup in a report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $174.60.

AptarGroup Price Performance

Shares of NYSE:ATR traded up $0.7670 on Friday, reaching $141.4070. The company's stock had a trading volume of 356,524 shares, compared to its average volume of 540,879. AptarGroup, Inc. has a 52-week low of $130.85 and a 52-week high of $178.03. The company has a market cap of $9.32 billion, a P/E ratio of 24.34, a PEG ratio of 2.93 and a beta of 0.57. The company has a 50-day simple moving average of $151.32 and a 200 day simple moving average of $149.72. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.83 and a current ratio of 1.21.

AptarGroup (NYSE:ATR - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.66 EPS for the quarter, topping analysts' consensus estimates of $1.58 by $0.08. AptarGroup had a net margin of 10.84% and a return on equity of 15.39%. The business had revenue of $966.01 million during the quarter, compared to analysts' expectations of $954.06 million. During the same period last year, the company posted $1.41 EPS. The business's revenue was up 6.1% on a year-over-year basis. AptarGroup has set its Q3 2025 guidance at 1.530-1.610 EPS. As a group, equities research analysts anticipate that AptarGroup, Inc. will post 5.57 EPS for the current fiscal year.

AptarGroup Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, August 14th. Stockholders of record on Thursday, July 24th were paid a $0.45 dividend. The ex-dividend date of this dividend was Thursday, July 24th. This represents a $1.80 annualized dividend and a dividend yield of 1.3%. AptarGroup's dividend payout ratio is currently 30.98%.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.